ERAS

Erasca is a drug development company working on cancer treatments that target a specific genetic mutation called RAS, which appears in many solid tumors. The company is testing several experimental drugs, including pills that block proteins in the RAS pathway and antibody treatments that work on cancer cells in a different way. Erasca was founded in 2018 and is based in San Diego.